{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:36:43Z","timestamp":1790429803360,"version":"4.1.0"},"reference-count":121,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T00:00:00Z","timestamp":1518739200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CH 806\/1-1, HI 1837\/1-1"],"award-info":[{"award-number":["CH 806\/1-1, HI 1837\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00163","type":"journal-article","created":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T23:14:28Z","timestamp":1518736468000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Autoantibodies in Autoimmune Hepatitis: Can Epitopes Tell Us about the Etiology of the Disease?"],"prefix":"10.3389","volume":"9","author":[{"given":"Urs","family":"Christen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Hintermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,2,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cld.2014.09.004","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"19","author":"Czaja","year":"2015","journal-title":"Clin Liver Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jaut.2012.11.002","article-title":"Autoimmune hepatitis: a comprehensive review","volume":"41","author":"Liberal","year":"2013","journal-title":"J Autoimmun"},{"key":"B3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11894-011-0236-2","article-title":"Diagnosis and treatment of autoimmune hepatitis","volume":"14","author":"Vierling","year":"2012","journal-title":"Curr Gastroenterol Rep"},{"key":"B4","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.bpg.2011.10.004","article-title":"Diagnostic criteria for autoimmune hepatitis","volume":"25","author":"Lohse","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1016\/j.jhep.2015.03.005","article-title":"Autoimmune hepatitis \u2013 update 2015","volume":"62","author":"Manns","year":"2015","journal-title":"J Hepatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S1089-3261(02)00021-1","article-title":"Prevalence and epidemiology of autoimmune hepatitis","volume":"6","author":"Boberg","year":"2002","journal-title":"Clin Liver Dis"},{"key":"B8","first-page":"55","article-title":"Autoimmune hepatitis-approach to diagnosis","volume":"8","author":"Czaja","year":"2006","journal-title":"MedGenMed"},{"key":"B9","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/hep.1840130415","article-title":"Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors","volume":"13","author":"Donaldson","year":"1991","journal-title":"Hepatology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/hep.1840190311","article-title":"Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis","volume":"19","author":"Doherty","year":"1994","journal-title":"Hepatology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/0016-5085(93)90157-8","article-title":"Significance of HLA DR4 in type 1 autoimmune hepatitis","volume":"105","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1155\/2013\/981086","article-title":"Challenges in the diagnosis and management of autoimmune hepatitis","volume":"27","author":"Czaja","year":"2013","journal-title":"Can J Gastroenterol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","article-title":"Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis","volume":"139","author":"Manns","year":"2010","journal-title":"Gastroenterology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.bpg.2011.08.003","article-title":"Therapy of autoimmune hepatitis","volume":"25","author":"Strassburg","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1007\/s10620-012-2151-2","article-title":"Advances in the current treatment of autoimmune hepatitis","volume":"57","author":"Czaja","year":"2012","journal-title":"Dig Dis Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.jhep.2010.12.032","article-title":"Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naive patients","volume":"55","author":"Zachou","year":"2011","journal-title":"J Hepatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/hep.28140","article-title":"Changing nomenclature for PBC: from \u2018cirrhosis\u2019 to \u2018cholangitis\u2019","volume":"62","author":"Beuers","year":"2015","journal-title":"Hepatology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J Hepatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/hep.21583","article-title":"A sensitive bead assay for antimitochondrial antibodies: chipping away at AMA-negative primary biliary cirrhosis","volume":"45","author":"Oertelt","year":"2007","journal-title":"Hepatology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev-pathol-020712-164014","article-title":"The immunobiology and pathophysiology of primary biliary cirrhosis","volume":"8","author":"Hirschfield","year":"2013","journal-title":"Annu Rev Pathol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s12016-015-8482-y","article-title":"Animal models of primary biliary cirrhosis","volume":"48","author":"Katsumi","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/hep.23783","article-title":"Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis","volume":"52","author":"Lleo","year":"2010","journal-title":"Hepatology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S1568-9972(03)00013-2","article-title":"Antinuclear antibodies specific for primary biliary cirrhosis","volume":"2","author":"Worman","year":"2003","journal-title":"Autoimmun Rev"},{"key":"B26","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1586\/17474124.2016.1121810","article-title":"Proposed therapies in primary biliary cholangitis","volume":"10","author":"Floreani","year":"2016","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/liv.13344","article-title":"Finding the cure for primary biliary cholangitis \u2013 still waiting","volume":"37","author":"Tanaka","year":"2017","journal-title":"Liver Int"},{"key":"B28","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N Engl J Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/liv.13294","article-title":"Old and new treatments for primary biliary cholangitis","volume":"37","author":"Chascsa","year":"2017","journal-title":"Liver Int"},{"key":"B30","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000440827","article-title":"Therapy of primary sclerosing cholangitis \u2013 today and tomorrow","volume":"33","author":"Halilbasic","year":"2015","journal-title":"Dig Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1002\/hep.24247","article-title":"Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"53","author":"Molodecky","year":"2011","journal-title":"Hepatology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1053\/j.gastro.2008.01.042","article-title":"The natural history of small-duct primary sclerosing cholangitis","volume":"134","author":"Bjornsson","year":"2008","journal-title":"Gastroenterology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.cgh.2015.05.035","article-title":"Primary sclerosing cholangitis as a premalignant biliary tract disease: surveillance and management","volume":"13","author":"Rizvi","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/j.jhep.2008.01.020","article-title":"The challenges in primary sclerosing cholangitis \u2013 aetiopathogenesis, autoimmunity, management and malignancy","volume":"48","author":"Weismuller","year":"2008","journal-title":"J Hepatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/j.cgh.2014.02.008","article-title":"Low risk of hepatocellular carcinoma in patients with primary sclerosing cholangitis with cirrhosis","volume":"12","author":"Zenouzi","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/j.1365-2036.2011.04822.x","article-title":"Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis","volume":"34","author":"Triantos","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"B38","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","article-title":"Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy","volume":"134","author":"Ghazale","year":"2008","journal-title":"Gastroenterology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J Hepatol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1155\/2013\/981086","article-title":"Diagnosis and management of the overlap syndromes of autoimmune hepatitis","volume":"27","author":"Czaja","year":"2013","journal-title":"Can J Gastroenterol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouilleres","year":"1998","journal-title":"Hepatology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.cgh.2010.03.004","article-title":"Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome","volume":"8","author":"Kuiper","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis","volume":"354","author":"Krawitt","year":"2006","journal-title":"N Engl J Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1111\/apt.13210","article-title":"Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype","volume":"41","author":"Muratori","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"B45","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0168-8278(99)80342-0","article-title":"Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis","volume":"31","author":"Kanzler","year":"1999","journal-title":"J Hepatol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/0016-5085(94)90078-7","article-title":"Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis","volume":"107","author":"Czaja","year":"1994","journal-title":"Gastroenterology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S0168-8278(96)80290-X","article-title":"Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases","volume":"25","author":"Strassburg","year":"1996","journal-title":"J Hepatol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.clinre.2013.04.005","article-title":"Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis","volume":"37","author":"Liberal","year":"2013","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/gut.2005.075002","article-title":"Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis","volume":"55","author":"Rigamonti","year":"2006","journal-title":"Gut"},{"key":"B50","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jaut.2013.08.001","article-title":"Clinical significance of autoantibodies in autoimmune hepatitis","volume":"46","author":"Liberal","year":"2013","journal-title":"J Autoimmun"},{"key":"B51","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s12016-013-8383-x","article-title":"Autoimmune features in metabolic liver disease: a single-center experience and review of the literature","volume":"45","author":"Tsuneyama","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jaut.2016.02.007","article-title":"Non-alcoholic fatty liver disease (NAFLD) potentiates autoimmune hepatitis in the CYP2D6 mouse model","volume":"69","author":"Muller","year":"2016","journal-title":"J Autoimmun"},{"key":"B53","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1080\/1744666X.2017.1327355","article-title":"Diagnostic approach to autoimmune hepatitis","volume":"13","author":"Muratori","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1172\/JCI113949","article-title":"Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1","volume":"83","author":"Manns","year":"1989","journal-title":"J Clin Invest"},{"key":"B55","doi-asserted-by":"publisher","first-page":"8256","DOI":"10.1073\/pnas.85.21.8256","article-title":"Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II","volume":"85","author":"Zanger","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1740-2557-1-2","article-title":"Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease","volume":"1","author":"Zachou","year":"2004","journal-title":"J Autoimmune Dis"},{"key":"B57","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/S1568-9972(03)00036-3","article-title":"Autoimmunity and hepatitis C","volume":"2","author":"Strassburg","year":"2003","journal-title":"Autoimmun Rev"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.2174\/138161208784746824","article-title":"HCV and autoimmunity","volume":"14","author":"Ferri","year":"2008","journal-title":"Curr Pharm Des"},{"key":"B59","doi-asserted-by":"publisher","first-page":"84","DOI":"10.2133\/dmpk.25.84","article-title":"LKM-1 sera from autoimmune hepatitis patients that recognize ERp57, carboxylesterase 1 and CYP2D6","volume":"25","author":"Komurasaki","year":"2010","journal-title":"Drug Metab Pharmacokinet"},{"key":"B60","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1053\/gast.2000.9366","article-title":"\u201cAtypical p-ANCA\u201d in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines","volume":"119","author":"Terjung","year":"2000","journal-title":"Gastroenterology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/S0140-6736(00)02166-8","article-title":"Identification of target antigen for SLA\/LP autoantibodies in autoimmune hepatitis","volume":"355","author":"Wies","year":"2000","journal-title":"Lancet"},{"key":"B62","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S0140-6736(94)91966-6","article-title":"Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D","volume":"344","author":"Philipp","year":"1994","journal-title":"Lancet"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/S0016-5085(96)70020-3","article-title":"Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis","volume":"111","author":"Strassburg","year":"1996","journal-title":"Gastroenterology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1155\/2000\/910107","article-title":"Target proteins in human autoimmunity: cytochromes P450 and UDP-glucuronosyltransferases","volume":"14","author":"Obermayer-Straub","year":"2000","journal-title":"Can J Gastroenterol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1081\/DMR-200028798","article-title":"Autoantibodies against CYP2D6 and other drug-metabolizing enzymes in autoimmune hepatitis type 2","volume":"37","author":"Mizutani","year":"2005","journal-title":"Drug Metab Rev"},{"key":"B66","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1055\/s-2008-1040439","article-title":"The asialoglycoprotein receptor as target structure in autoimmune liver diseases","volume":"11","author":"Poralla","year":"1991","journal-title":"Semin Liver Dis"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1053\/gast.2001.24227","article-title":"Autoimmune hepatitis: clinical challenges","volume":"120","author":"Manns","year":"2001","journal-title":"Gastroenterology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2015.07.021","article-title":"Autoantibodies to asialoglycoprotein receptor (ASGPR) in patients with autoimmune liver diseases","volume":"450","author":"Villalta","year":"2015","journal-title":"Clin Chim Acta"},{"key":"B69","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1053\/jhep.2002.32092","article-title":"Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease","volume":"35","author":"Ma","year":"2002","journal-title":"Hepatology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S0168-8278(86)80026-5","article-title":"Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders","volume":"3","author":"McFarlane","year":"1986","journal-title":"J Hepatol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1600-0676.1987.tb00361.x","article-title":"Immunoglobulin on the surface of isolated hepatocytes is associated with antibody-dependent cell-mediated cytotoxicity and liver damage","volume":"7","author":"Vergani","year":"1987","journal-title":"Liver"},{"key":"B72","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/hep.1840110521","article-title":"Presence of functional cytochrome P-450 on isolated rat hepatocyte plasma membrane","volume":"11","author":"Loeper","year":"1990","journal-title":"Hepatology"},{"key":"B73","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1365-2249.1993.tb03409.x","article-title":"Cytochrome P450IID6 recognized by LKM1 antibody is not exposed on the surface of hepatocytes","volume":"92","author":"Yamamoto","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"B74","first-page":"225","article-title":"Lack of surface expression for the B-cell autoepitope of cytochrome P450 IID6 evidenced by flow cytometry","volume":"31","author":"Trautwein","year":"1993","journal-title":"Z Gastroenterol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1136\/adc.67.12.1447","article-title":"Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis","volume":"67","author":"Senaldi","year":"1992","journal-title":"Arch Dis Child"},{"key":"B76","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.bpg.2011.09.009","article-title":"Pathogenesis of autoimmune hepatitis","volume":"25","author":"Liberal","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jaut.2012.11.001","article-title":"Molecular mimicry rather than identity breaks T-cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis","volume":"42","author":"Ehser","year":"2013","journal-title":"J Autoimmun"},{"key":"B78","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jaut.2016.12.001","article-title":"The influence of genetic predisposition and autoimmune hepatitis inducing antigens in disease development","volume":"78","author":"Hardtke-Wolenski","year":"2017","journal-title":"J Autoimmun"},{"key":"B79","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/0896-8411(91)90180-K","article-title":"Identification of the main epitope on human cytochrome P450 IID6 recognized by anti-liver kidney microsome antibody","volume":"4","author":"Gueguen","year":"1991","journal-title":"J Autoimmun"},{"key":"B80","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1006\/jaut.2001.0565","article-title":"Differences in anti-LKM-1 autoantibody immunoreactivity to CYP2D6 antigenic sites between hepatitis C virus-negative and -positive patients","volume":"17","author":"Kitazawa","year":"2001","journal-title":"J Autoimmun"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1172\/JCI115443","article-title":"LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase","volume":"88","author":"Manns","year":"1991","journal-title":"J Clin Invest"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/eji.1830230519","article-title":"Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti-liver-kidney microsome type-1 antibodies (LKM1)","volume":"23","author":"Yamamoto","year":"1993","journal-title":"Eur J Immunol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1084\/jem.20071859","article-title":"Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection","volume":"205","author":"Holdener","year":"2008","journal-title":"J Exp Med"},{"key":"B84","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jaut.2011.06.005","article-title":"Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model","volume":"37","author":"Hintermann","year":"2011","journal-title":"J Autoimmun"},{"key":"B85","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1046\/j.1365-2249.1999.01027.x","article-title":"Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes","volume":"118","author":"Klein","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.4049\/jimmunol.170.3.1481","article-title":"Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus\/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease","volume":"170","author":"Kerkar","year":"2003","journal-title":"J Immunol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1248\/bpb.28.2240","article-title":"A new epitope of CYP2D6 recognized by liver kidney microsomal autoantibody from Japanese patients with autoimmune hepatitis","volume":"28","author":"Imaoka","year":"2005","journal-title":"Biol Pharm Bull"},{"key":"B88","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/0891693021000069556","article-title":"A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450 autoantigens","volume":"35","author":"Sugimura","year":"2002","journal-title":"Autoimmunity"},{"key":"B89","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1365-2249.1991.tb08164.x","article-title":"Clonal analysis of liver-infiltrating T cells in patients with LKM-1 antibody-positive autoimmune chronic active hepatitis","volume":"84","author":"Lohr","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1002\/hep.510240619","article-title":"Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis","volume":"24","author":"Lohr","year":"1996","journal-title":"Hepatology"},{"key":"B91","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1053\/j.gastro.2005.12.020","article-title":"Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2","volume":"130","author":"Ma","year":"2006","journal-title":"Gastroenterology"},{"key":"B92","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/hep.21658","article-title":"Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2","volume":"46","author":"Longhi","year":"2007","journal-title":"Hepatology"},{"key":"B93","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2307\/3276622","article-title":"Common antigens between adult Schistosoma mansoni and the laboratory mouse","volume":"53","author":"Damian","year":"1967","journal-title":"J Parasitol"},{"key":"B94","first-page":"127","article-title":"Molecular mimicry as a mechanism for the cause and as a probe uncovering etiologic agent(s) of autoimmune disease","volume":"145","author":"Oldstone","year":"1989","journal-title":"Curr Top Microbiol Immunol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.molimm.2003.11.014","article-title":"Induction, acceleration or prevention of autoimmunity by molecular mimicry","volume":"40","author":"Christen","year":"2004","journal-title":"Mol Immunol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaut.2009.08.001","article-title":"Viral triggers for autoimmunity: is the \u2018glass of molecular mimicry\u2019 half full or half empty?","volume":"34","author":"Christen","year":"2010","journal-title":"J Autoimmun"},{"key":"B97","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/B978-0-444-56378-1.00004-6","article-title":"Molecular mimiry","volume-title":"Autoantibodies","author":"Christen","year":"2014"},{"key":"B98","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3109\/08830185.2014.921162","article-title":"Pathogen infection and autoimmunity","volume":"33","author":"Christen","year":"2014","journal-title":"Int Rev Immunol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1172\/JCI17005","article-title":"Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient","volume":"113","author":"Christen","year":"2004","journal-title":"J Clin Invest"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1172\/JCI38503","article-title":"Immunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in mice","volume":"119","author":"Filippi","year":"2009","journal-title":"J Clin Invest"},{"key":"B101","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/358155a0","article-title":"Spreading of T-cell autoimmunity to cyptic determinants of an autoantigen","volume":"358","author":"Lehmann","year":"1992","journal-title":"Nature"},{"key":"B102","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jaut.2017.07.003","article-title":"Development of autoantibodies precedes clinical manifestations of autoimmune diseases: a comprehensive review","volume":"83","author":"Ma","year":"2017","journal-title":"J Autoimmun"},{"key":"B103","doi-asserted-by":"publisher","first-page":"e3644","DOI":"10.3791\/3644","article-title":"The CYP2D6 animal model: how to induce autoimmune hepatitis in mice","volume":"60","author":"Hintermann","year":"2012","journal-title":"J Vis Exp"},{"key":"B104","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.2174\/1381612821666150316121319","article-title":"An update on animal models of autoimmune hepatitis: are we there yet?","volume":"21","author":"Christen","year":"2015","journal-title":"Curr Pharm Des"},{"key":"B105","doi-asserted-by":"publisher","first-page":"277","DOI":"10.4049\/jimmunol.169.1.277","article-title":"Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule","volume":"169","author":"Ma","year":"2002","journal-title":"J Immunol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/0140-6736(90)90070-L","article-title":"Type 2 autoimmune hepatitis and hepatitis C virus infection","volume":"335","author":"Lenzi","year":"1990","journal-title":"Lancet"},{"key":"B107","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3109\/08916930108994106","article-title":"Immunoreactivity to various human cytochrome P450 proteins of sera from patients with autoimmune hepatitis, chronic hepatitis B, and chronic hepatitis C","volume":"33","author":"Miyakawa","year":"2001","journal-title":"Autoimmunity"},{"key":"B108","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/hep.1840160304","article-title":"Liver\/kidney microsome antibody type 1 and hepatitis C virus infection","volume":"16","author":"Lunel","year":"1992","journal-title":"Hepatology"},{"key":"B109","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0140-6736(92)91332-3","article-title":"Anti-GOR and hepatitis C virus in autoimmune liver diseases","volume":"339","author":"Michel","year":"1992","journal-title":"Lancet"},{"key":"B110","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/hep.20816","article-title":"LKM1 autoantibodies in chronic hepatitis C infection: a case of molecular mimicry?","volume":"42","author":"Marceau","year":"2005","journal-title":"Hepatology"},{"key":"B111","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3109\/03602538909103537","article-title":"Neoantigens associated with halothane hepatitis","volume":"20","author":"Pohl","year":"1989","journal-title":"Drug Metab Rev"},{"key":"B112","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0163-7258(93)90047-H","article-title":"Mechanisms of halothane toxicity: novel insights","volume":"58","author":"Gut","year":"1993","journal-title":"Pharmacol Ther"},{"key":"B113","first-page":"631","article-title":"Halothane hepatitis","volume":"10","author":"Neuberger","year":"1998","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1021\/bi00057a013","article-title":"Halothane metabolism: the dihydrolipoamide acetyltransferase subunit of the pyruvate dehydrogenase complex molecularly mimics trifluoroacetyl-protein adducts","volume":"32","author":"Christen","year":"1993","journal-title":"Biochemistry"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/j.1432-1033.1994.tb19082.x","article-title":"Identification of the dihydrolipoamide acetyltransferase subunit of the human pyruvate dehydrogenase complex as an autoantigen in halothane hepatitis. Molecular mimicry of trifluoroacetyl-lysine by lipoic acid","volume":"223","author":"Christen","year":"1994","journal-title":"Eur J Biochem"},{"key":"B116","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/0140-6736(93)92005-E","article-title":"Autoantibodies to hepatic microsomal carboxylesterase in halothane hepatitis","volume":"342","author":"Smith","year":"1993","journal-title":"Lancet"},{"key":"B117","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1432-1033.1992.tb17042.x","article-title":"The kidney as a novel target tissue for protein adduct formation associated with metabolism of halothane and the candidate chlorofluorocarbon replacement 2,2-dichloro-1,1,1-trifluoroethane","volume":"207","author":"Huwyler","year":"1992","journal-title":"Eur J Biochem"},{"key":"B118","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1097\/00000542-200203000-00036","article-title":"Subcellular localization of trifluoroacetylated liver proteins in association with hepatitis following isoflurane","volume":"96","author":"Njoku","year":"2002","journal-title":"Anesthesiology"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1213\/01.ane.0000263275.10081.47","article-title":"Desflurane hepatitis associated with hapten and autoantigen-specific IgG4 antibodies","volume":"104","author":"Anderson","year":"2007","journal-title":"Anesth Analg"},{"key":"B120","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S0140-6736(97)03094-8","article-title":"Epidemic of liver disease caused by hydrochlorofluorocarbons used as ozone-sparing substitutes of chlorofluorocarbons","volume":"350","author":"Hoet","year":"1997","journal-title":"Lancet"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2017.10.006","article-title":"Serology in autoimmune hepatitis: a clinical-practice approach","author":"Terziroli Beretta-Piccoli","year":"2017","journal-title":"Eur J Intern Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00163\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T23:14:36Z","timestamp":1518736476000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00163\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,16]]},"references-count":121,"alternative-id":["10.3389\/fimmu.2018.00163"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00163","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732801202.793547468","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,16]]},"article-number":"163"}}